Login / Signup

Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.

Daniel PauleikhoffRoberto BonelliAdam Michael DubisFrederic GunnemannKai RothausPeter Charbel IssaTjebo F C HeerenTunde PetoTraci E ClemonsEmily Y ChewAlan C BirdFerenc B Sallonull null
Published in: Acta ophthalmologica (2019)
Ellipsoid zone (EZ) loss in MacTel has a non-linear progression characteristic, and its rate depends on area size at baseline, which must be taken into account at sample selection in clinical trials. Our results show a good correlation of linear and area measures of EZ loss and a segregation of best-corrected visual acuity by EZ location, which may help routine clinical practice.
Keyphrases
  • clinical practice
  • clinical trial
  • optical coherence tomography
  • diabetic retinopathy
  • randomized controlled trial
  • open label
  • study protocol